Democritus University of Thrace (DUTH)
Μορφολογική και ανοσοϊστοχημική μελέτη ουροθηλιακών νεοπλασμάτων κύστεως σε σχέση με την πρόγνωση
Abstract
dc:descriptionThe human epidermal growth factor receptors (HER) protein family consists of four different transmembrane receptors (HER1–HER4). The dimerization of HER members leads to the activation of intracellular RAS/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways, which plays an important role in cell proliferation, angiogenesis, invasion, and metastasis. The activation of PI3K/AKT/PTEN/mTOR pathway has been implicated in carcinogenesis or malignant potential of several cancers, including urothelial ones. The present study was conducted to investigate the expression of EGFR and HER2 proteins, as well as intracellular signaling molecules in sections of urothelial carcinomas by immunohistochemistry. In addition, we try to find out if there is any association between the protein expression of this pathway with the expression of cell adhesion molecules, such as e-cadherin, p-cadherin, and b-catenin, and with conventional clinicopathologic parameters. For these purposes, forty-one paraffin-embedded urothelial cancer tissue blocks, with adequate material and clinical follow-up, were collected. Immunostains for HER2, EGFR, MIB1, phospho-AKT, PTEN, phospho-mTOR, e-cadherin, p-cadherin, and b-catenin were performed on tissue microarrays sections. The overexpression of HER2 was found in 19.6% of the cases and it was associated with high grade tumors, high mitotic index and phosphorylation of AKT and mTOR. Muscle-invasive tumors presented both cytoplasmic and nuclear losses of PTEN expression. Two of the cases with HER2 overexpression (HER2 3+) were of high grade and they were characterized by pAKT and pmTOR protein overexpression and PTEN nuclear deletion. These patients presented the worst prognosis in this study. There was no association between HER/AKT/mTOR pathway activation and CAM expression. Although cadherins were often coexpressed, only p-cadherin immunoreactivity was associated with tumor grade and high proliferative index. In conclusion, it is demonstrating that the combination of pAKT and pmTOR expression along with a loss of PTEN expression, which reflects to an activated pathway, does not influence the expression of CAMs and it is associated with adverse clinicopathological characteristics. Hence, these patients could be the most appropriate candidates for targeted therapy, when conventional therapy fails, taking into account the side effects of these therapeutic options. The increased interest to personalize therapy leads to a thorough investigation of patients who will benefit the most from a particular treatment.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2018
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Koletsas, Nikolaos
- Κολέτσας, Νικόλαος
Subjects
dc:subject × 14- Μορφολογική και ανοσοϊστοχημική μελέτη ουροθηλιακών νεοπλασμάτων κύστεως σε σχέση με την πρόγνωση
- Ενδοκυττάρια μονοπάτια μετάδοσης σήματος
- Ιστικές μικροσυστοιχίες
- Μορφολογική και ανοσοϊστοχημική μελέτη
- Ουροθηλιακά νεοπλάσματα κύστεως
- Morphological and immunohistochemical study of urothelial bladder neoplasms in relation to prognosis
- Intracellular signal transduction pathways
- Tissue microarrays
- Morphological and immunohistochemical study
- Urothelial bladder neoplasms
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
dc:rights- Statement dc:rights
-
- BY_NC_ND
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/43408